Industrie

• Azzeramento di tutti ×
• Assistenza sanitaria & Scienze di vita ×
• Cina ×

Showing 31–40 Di 44 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Bladder Cancer Market in China

  Secondo StrategyHelix, the bladder cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.1% nel periodo di analisi di 2021 A 2027.

  Dollaro statunitense 5
• 

  Pancreatic Cancer Market in China

  According to a statistic by StrategyHelix, the pancreatic cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.3% durante il periodo di previsione (2021-2027).

  Dollaro statunitense 5
• 

  Lymphoma Market in China

  Secondo StrategyHelix, the lymphoma market in China, in terms of volume, is expected to expand at a CAGR of 2.3% in the next five years.

  Dollaro statunitense 10
• 

  Urothelial Cancer Market in China

  According to a statistic by StrategyHelix, the urothelial cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.2% da 2021 Attraverso 2027.

  Dollaro statunitense 5
• 

  Gastric Cancer Market in China

  The gastric cancer market in China was estimated at 470 thousand units in 2020 and is anticipated to reach 579 thousand units by 2027, procedendo a un CAGR di 3% throughout the forecast period, secondo StrategyHelix.

  Dollaro statunitense 10
• 

  Breast Cancer Market in China

  Secondo StrategyHelix, the breast cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% da 2021 Attraverso 2027.

  Dollaro statunitense 5
• 

  Non-small-cell Lung Carcinoma (NSCLC) Market in China

  At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 10
• 

  Nasopharyngeal Cancer Market in China

  According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% in the next five years.

  Dollaro statunitense 5
• 

  Head and Neck Cancer Market in China

  The head and neck cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.7% da 2021 Attraverso 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 5
• 

  Oncology Drug Market in China

  The oncology drug market in China is poised to grow at a CAGR of around 13.3% nel periodo di analisi di 2021 A 2027, secondo la società di dati e analisi StrategyHelix.

  Dollaro statunitense 10